News headlines about Neogen (NASDAQ:NEOG) have been trending somewhat positive on Wednesday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Neogen earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave press coverage about the company an impact score of 44.7386489445311 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Neogen (NASDAQ:NEOG) traded up $0.16 during trading hours on Wednesday, hitting $63.82. 171,339 shares of the stock were exchanged, compared to its average volume of 175,505. Neogen has a twelve month low of $44.63 and a twelve month high of $64.44. The company has a market cap of $3,260.35, a PE ratio of 63.34, a P/E/G ratio of 3.92 and a beta of 1.42.
Neogen (NASDAQ:NEOG) last released its quarterly earnings results on Wednesday, January 3rd. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.07. Neogen had a net margin of 13.47% and a return on equity of 10.72%. The business had revenue of $101.80 million for the quarter, compared to analysts’ expectations of $102.46 million. During the same period last year, the business earned $0.29 EPS. The company’s revenue was up 12.2% compared to the same quarter last year. sell-side analysts predict that Neogen will post 1.08 earnings per share for the current year.
In related news, insider James L. Herbert sold 25,334 shares of Neogen stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $59.32, for a total value of $1,502,812.88. Following the completion of the sale, the insider now directly owns 1,157,591 shares in the company, valued at approximately $68,668,298.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Steven J. Quinlan sold 2,000 shares of Neogen stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $60.15, for a total transaction of $120,300.00. Following the completion of the sale, the chief financial officer now owns 15,470 shares of the company’s stock, valued at $930,520.50. The disclosure for this sale can be found here. Insiders sold a total of 66,382 shares of company stock worth $3,939,913 over the last 90 days. Company insiders own 4.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by BBNS and is the sole property of of BBNS. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://baseballnewssource.com/2018/03/14/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-neogen-neog-share-price/1890327.html.
Neogen Company Profile
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.